LEADGENE
Language
EN
TW
Leadgene Leadgene
  • Products
    Products
    Product Types
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
    Resources
    • Chronic Kidney Disease
    • Nipah Virus
    • COVID-19
    • Cell Biology
    • Cardiovascular
    • Cancer
    • Dengue Virus
    • Epigenetics and Nuclear Signaling
    • Enterovirus
    • Human Respiratory Ryncytial Virus
    • Hepatitis B Virus
    • Influenza Virus
    • Isotype and Loading Controls
    • Immunology
    • Neuroscience
    • Organoid
    • Signal Transduction
    • Tags and Cell Markers
    • Zika Virus
    Close
  • Services
    Services

    Services

    We Innovate.
    We Explore.
    We Contribute.

    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Animal Model Analysis
    Close
  • Chronic Kidney Disease
    Chronic Kidney Disease

    Chronic Kidney Disease

    Hello, Kidney Health!

    • Health Education
    • Products
    Close
  • Quality
    Quality

    Quality

    Excellence in Our Profession
    Through Attention to Detail.

    • Quality Control
    Close
  • Support
    Support

    Support

    Bring You a New Vision of the World.

    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
    Close
  • Company
    Company

    Company

    Details make our Profession.

    • About us
    • Contact Us
    • Distributors
    • News
    Close
  • Product Search
    COA Search
LEADGENE / Company

News

Latest News

2021.06.02

Leadgene Biomedical Launches High-Profile COVID-19 Products and Gears Up for The Pandemic

2021.03.26

Leadgene Biomedical, Inc. Announces an Ambitious Investment in Southern Taiwan.

2021.03.11

World Kidney Day 2021.3.11

2020.06.12

Leadgene Biomedical, Inc. Announces a Great Cooperation with Abnova on Development of COVID-19 Therapeutic Antibodies

2020.05.19

An Interview with Leadgene Biomedical CEO Louis Cheng - Pharma Boardroom

2020.05.05

Taiwan Biotech Companies Showcase Brilliant Detection Solutions against COVID-19 Pandemic

2020.02.11

Looking Forward Partners That Leadgene Is Going to Assist for Free in the Development of 2019-nCoV Antibody.

2019.11.13

Leadgene Biomedical Achieves the 73rd Tainan County Industrial Association Outstanding Award

  • 2
  • 3
  • 4
  • Products
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
  • Services
    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Animal Model Analysis
  • Chronic Kidney Disease
    • Health Education
    • Products
  • Quality
    • Quality Control
  • Support
    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
  • Company
    • About us
    • Contact Us
    • Distributors
    • News
  • Terms and Conditions
  • Privacy Policy
© 2025 LEADGENE BIOMEDICAL, INC. All rights reserved.
This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.